TP53 and colonic neoplasm: m6A methylation by METTL3 at the point-mutated codon 273 (G > A) of p53 pre-mRNA promoted a preferential pre-mRNA splicing that produced p53 R273H mutant genes that were resistant to multiple anticancer drugs in colon cancer cells [1015].